InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.750
-0.070 (-2.48%)
At close: Jul 11, 2025, 4:00 PM
2.750
0.00 (-0.01%)
After-hours: Jul 11, 2025, 5:59 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $3.32 million as of July 11, 2025. Its market cap has increased by 50.90% in one year.
Market Cap
3.32M
Enterprise Value
-552.05K
1-Year Change
50.90%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $3.32M, a decrease of -87.23%. That is a compound annual growth rate of -35.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 3.30M | -2.94% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |